Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: A randomized study comparing trapidil plus ticlopidine with heparin treatment

Hepatology

Volumn 29, Issue 1, 1999, Pages 33-38

  Siegerstetter, Volker ^a   Huber, Michael ^a   Ochs, Andreas ^a   Blum, Hubert E ^a   Rössle, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; PLATELET DERIVED GROWTH FACTOR; TICLOPIDINE; TRAPIDIL;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD FLOW VELOCITY; CHRONIC LIVER DISEASE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PORTAL VEIN; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; TREATMENT OUTCOME;

DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HEMODYNAMIC PROCESSES; HEPARIN; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET-DERIVED GROWTH FACTOR; PORTAL SYSTEM; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; TICLOPIDINE; TIME FACTORS; TRAPIDIL; VASCULAR PATENCY;

EID: 0032923586     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290139     Document Type: Article

References (26)

1. Rössle M, Haag K, Ochs A, Sellinger M, Nöldge G, Perarnau J-M, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994;330:165-171.
2. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, et al. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology 1993;187:413-420.
3. Theilmann L, Sauer P. Transjugular intrahepatic portasystemic stent shunt: results and complications. Radiologe 1994;34:174-177.
4. Lind CD, Malisch TW, Chong WK, Richards WO, Pinson CW, Meranze SG, et al. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gasiroemerology 1994;106:1277-1283.
5. Rossi P, Bezzi M, Salvatori FM, Broglia L, Maccioni F, Pizzi G, et al. Self-expanding stents in transjugular intrahepatic portosystemic shunt: experience with nitinol Strecker stents. Eur Radiol 1996;6:741-747.
6. Forster J, Delcore R, Payne KM, Siegel EL. The role of transjugular intrahepatic portosystemic shunts in the management of patients with end-stage liver disease. Am J Surg 1994;168:592-596.
7. Rousseau H, Vinel JP, Bilbao JI, Longo JM, Maquin P, Zozaya JM, et al. Transjugular intrahepatic portosystemic shunts using the Wallstent prosthesis: a follow-up study. Cardiovasc Intervent Radiol 1994;17:7-11.
8. Hausegger KA, Sternthal HM, Klein GE, Karaic R, Stauber R, Zenker G. Transjugular intrahepatic portosystemic shunt: angiographie follow-up and secondary interventions. Radiology 1994;191:177-181.
9. Haskal ZJ, Pentecost MJ, Soulen MC, Shlansky-Goldberg RD, Baum RA, Cope C. Transjugular intrahepatic portosystemic shunt stenosis and revision: early and midterm results. Am J Roentgenol 1994;163:439-444.
10. Chong WK, Malisch TA, Mazer MJ, Lind CD, Worrell JA, Richards WO. Transjugular intrahepatic portosystemic shunt: US assessment with maximum flow velocity. Radiology 1993;189:789-793.
11. LaBerge JM, Ferrell LD, Ring EJ, Gordon RL. Histopathologic study of stenotic and occluded transjugular intrahepatic portosystemic shunts. J Vase Interv Radiol 1993;4:779-786.
12. Ducoin H, El-Khoury J, Rousseau H, Barange K, Peron JM, Pierragi MT, et al. Histopathologic analysis of transjugular intrahepatic portosystemic shunts. HEPATOLOGY 1997;25:1064-1069.
13. Palmaz JC. Balloon-expandable intravascular stent. Am J Roentgenol 1988;150:1263-1269.
14. Nöldge G, Richter GM, Siegerstetter V, Garcia O, Palmaz JC. Tierexperimentelle Untersuchungen über den Einflub der Flubrestriktion auf die Thrombogenität des Palmaz-Stentes mittels 111Indium-markierter Thrombozyten. Fortschr Geb Röntgenstrahlen Neuen Bildgeb Verfahr 1990;152:264-270.
15. Theilmann L, Sauer P, Roeren T, Otto G, Arnold JC, Noeldge G, et al. Acetylsalicylic acid in the prevention of early stenosis and occlusion of transjugular intrahepatic portal-systemic stent shunts: a controlled study. HEPATOLOGY 1994;20:592-597.
16. Sauer P, Theilmann L, Herrmann S, Bruckner T, Roeren T, Richter G, et al. Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: a randomized trial. HEPATOLOGY 1996;24:1433-1436.
17. Zemel G, Katzen BT, Becker GJ, Benenati JF, Sallee DS. Percutaneous transjugular portosystemic shunt. JAMA 1991;266:390-393.
18. Do-dai-Do, Triller J, Walpoth BH, Stirnemann P, Mahler F. A comparison study of self-expandable stents vs balloon angioplasty alone in femoropopliteal artery occlusions. Cardiovasc Intervent Radiol 1992;15:306-312.
19. Kuntz RE, Gibson CM, Nobuyoshi M, Baim DS. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 1993;21:15-25.
20. Sigwart U. [Coronary endoprostheses (stents)]. Herz 1990;15:319-328.
21. Ross R. Platelet-derived growth factor. Annu Rev Med 1987;38:71-79.
22. LoGerfo FW, Quist WC, Nowak MD, Crawshaw HM, Haudenschild CC. Downstream anastomotic hyperplasia. A mechanism of failure in Dacron arterial grafts. Ann Surg 1983;197:479-483.
23. Taubman MB. Gene induction in vessel wall injury. Thromb Haemost 1993;70:180-183.
24. Marmur JD, Poon M, Rossikhina M, Taubman MB. Induction of PDGF-responsive genes in vascular smooth muscle. Implications for the early response to vessel injury. Circulation 1992;86:53-60.
25. Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb 1993;13:1218-1226.
26. Leung DY, Glagov S, Mathews MB. Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science 1976;191:475-477.